This study was conducted to determine the frequency and contribution of chromosomal abnormalities in miscarriages and in couples with recurrent in vitro fertilization/ intra cytoplasmic sperm injection (IVF/ICSI) failure.
It is demonstrated by the high frequency of abnormalities found in sample fetal or embryonic tissue. [1] When a woman has had two or more miscarriages, she will be under the care of gynecologist to seek professional help in the hope that a cause and care will be found. [2] In the other way, the development of IVF and ICSI and related techniques has increased the possibility of obtaining babies from infertile patients. Today recurrent implantation failure is the major reason for women completing several IVF/ICSI attempts without having achieved a child, and is probably also the explanation for many cases of unexplained infertility. Most causes of recurrent miscarriage are still poorly elucidated, but from a theoretical point of view recurrent implantation failure and recurrent miscarriage are suggested to have partly overlapping causes. [3] It is well known that lower implantation rate and higher spontaneous abortions rate are closely related with the chromosomal abnormalities of both parents. Even in some patients, unexplained multiple IVF/ICSI failure has been frequently reported. [4] An association between human infertility and chromosomal abnormalities has been known for long time; [5] thus, it would not be unusual to Þ nd chromosomal abnormalities in couples attending an infertility clinic.
Studies of Gianaroli et al. showed that infertile patients with poor prognosis have an increased risk of having embryos with chromosomal abnormality, which could be one of the main reasons of implantation failure or recurrent spontaneous abortions. [6] With the development of Assisted
Reproduction Technologies (ART), genetic counseling and screening of couples take a greater importance. As a all previous pregnancies and those who have had one successful pregnancy followed by consecutive losses. [7] In the present study, the patients had a history of three metaphases from two independent cell cultures were analyzed. All chromosomal abnormalities were reported in accordance with the current international standard nomenclature. [8] The χ 2 -test and one way analysis of variance (ANOVA) were used for statistical evaluation by SPSS software (version 11.5). The level of P < 0.05 was considered as signiÞ cance.
Results
The median age of male partners was 35.36 ± 0.85 and the median age of female partners was 31.0 ± 1.1.
There did not appear to be an age-related distribution of gonosomal aberrations. The results obtained are summarized in Tables 1-3 Abnormal karyotypes were found in 21 (9.50%) of the 221 subjects studied. We were not aware of any data available on the rate of anomalies in an equivalent fertile population. Of these 21 subjects, 4 (19.04%) exhibited sex chromosomal abnormalities. The remaining 17 Inversion of chromosome 9, normally not considered as a pathological chromosome alteration, was also included in Table 1 for the sake of completeness. The frequency of aberrations was 5.88% in the male partners.
Numerical or structural abnormalities were documented in 3.61% of the female partners. There was signiÞ cant difference for the rate of aberrations between male and female partners (P < 0.05) [ Figure 2 ].
The results also were analyzed according to the group of patients and are shown in Table 3 and Figures 1 and   2 . The rate of anomalies was higher in both male and female with recurrent abortions history than those who had IVF/ICSI failure (P < 0.05). Statistical analysis of data showed a statistically signiÞ cant difference for the rate of abnormalities between the two groups under investigation.
Discussion
Most of the spontaneous miscarriages are caused by chromosomal abnormalities in the embryo or fetus. [9] [10] [11] The genetic factors represent more than 50% of early gestation spontaneous abortion and associated with fetal chromosomal abnormalities. [12] The genetic etiology for multiple spontaneous pregnancy loss includes an unbalanced chromosome rearrangement, which may be the result of one parent being a carrier for a balanced chromosome rearrangement. [13] In 4-8% of couples with recurrent pregnancy loss, at least one of the partners has chromosomal abnormality that probably contains balance chromosomal abnormalities. [2] The results of the present study showed 13.92% chromosomal abnormalities in these individuals [ Figure 1 ]. The prevalence of chromosomal aberrations among couples with repeated spontaneous abortions varied in different studies, from none [14] to as high as 21.4%. [15] In the present study, incidence of chromosomal abnormalities among studied couples with repeated abortions was 13.92% which is higher than chromosomal aberrations prevalence among couples with repeated abortions found by Pescia et al. (5%), [16] Palanduz et al. (6.5%), [17] Al Hussain et al.
(7.7%), [18] and Mohammed (7.8%), [19] but close to that reported by Butler and Hamill (17.8%). [20] On the other hand, the types of abnormalities can play an important role in the effect of aberration. Fryns and Van Buggenhout reported that of the chromosome abnormalities observed in couples with repeated abortions, two-thirds were balanced autosomal translocations. [21] The rate of these abnormalities in this research was less than their report and was 14.28% of all the aberrations. X-chromosome mosaicism, which was seen in our karyotypes, is usually associated with abnormal development and reproductive performance, including recurrent spontaneous abortion. [22] We demonstrated X-chromosome mosaicism in two females (1.68%) out of 119 women experiencing recurrent abortion and IVF/ICSI failure. However, the reproductive performance of X-chromosome mosaicism is highly variable and difÞ cult to deÞ ne. [23] The incidence of karyotype abnormalities among infertile men has been reported to range between 2.2% and 19.6% [24] [25] [26] and numerical or structural abnormalities have been documented in near 10% of the female partners [27] similar to our observations shown in Figure 2 . Moreover, other studies showed that structural chromosomal abnormality is the most common chromosomal abnormality in couples with recurrent abortions especially couples undergoes ART. [28, 29] In vitro fertilization plus preimplantation genetic diagnosis (PGD) is an important step in the management of these couples. [10] One in 500 people carries a balanced translocation. When one member of a couple carries a balanced chromosome translocation, the risk of having a miscarriage is approximately doubled. In 3-5% of couples with recurrent miscarriage, one partner has a balanced translocation. [2] According to some researches, early on, genetically normal and abnormal embryos have similar appearance. On the basis of morphology alone, the genetic integrity cannot be determined; therefore, transferring of embryo in IVF and ICSI is some how risky and nonselective, so the risk of transferring the abnormal embryo is still persist. It can be resulted in IVF or ICSI fail. [30, 31] The commonly reported human inversion was inversion (9) (p12;q13). The role of pericentric inversion of chromosome 9 in infertility and pregnancy losses is still very controversial. [32] Although inversion (9) has been associated with repeated spontaneous abortions in several families, studies on unselected series of couples have usually failed to demonstrate a relationship between inversion (9) and repeated abortions. [33, 34] This study has shown that the incidence and distribution of total chromosomal abnormalities among our patients are comparable to that reported worldwide. In the future to complete this study, cytogenetic analysis of the abort uses should be done, which help the family in other pregnancies. In other research has indeed documented that both syndromes can be caused by the same embryonic chromosomal abnormalities and the same maternal endocrine, thrombophilic, and immunological disturbances. Consequently, many treatments attempting to normalize these abnormalities have been tested or are currently used in women with both recurrent implantation failure and recurrent miscarriage. However, no treatment for the two syndromes is at the moment sufÞ ciently documented to justify its routine use. [3] We concluded from all the previous results that cytogenetic studies 
